Insulet Corporation - Common Stock (PODD)
221.11
-14.96 (-6.34%)
NASDAQ · Last Trade: Mar 13th, 2:55 PM EDT
Friday's session: top gainers and losers in the S&P500 indexchartmill.com
Via Chartmill · March 13, 2026
Friday's session: gap up and gap down stock in the S&P500 indexchartmill.com
Via Chartmill · March 13, 2026
Top S&P500 movers in Friday's pre-market sessionchartmill.com
Via Chartmill · March 13, 2026
Discover the top S&P500 movers in Thursday's after-hours session.chartmill.com
Via Chartmill · March 12, 2026
Hitting a new 52-week low can be a pivotal moment for any stock.
These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
Via StockStory · February 26, 2026
Insulet Corp (NASDAQ:PODD): A High-Growth Stock Forming a Technical Basechartmill.com
Via Chartmill · February 25, 2026
Insulet Corp. (NASDAQ:PODD) Reports Strong Q4 Earnings Beat Amid Mixed 2026 Guidancechartmill.com
Via Chartmill · February 18, 2026
Insulet Corp (NASDAQ:PODD): A Prime GARP Candidate in Diabetes Carechartmill.com
Via Chartmill · February 17, 2026
Insulet Corp (NASDAQ:PODD) Matches Key Growth Rules in Navellier's "Little Book" Strategychartmill.com
Via Chartmill · February 4, 2026
Explore the top gainers and losers within the S&P500 index in today's session.chartmill.com
Via Chartmill · February 20, 2026
Friday's session: gap up and gap down stock in the S&P500 indexchartmill.com
Via Chartmill · February 20, 2026
Which S&P500 stocks are moving on Thursday?chartmill.com
Via Chartmill · February 19, 2026
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 31.2% year on year to $783.8 million. The company expects next quarter’s revenue to be around $716.9 million, close to analysts’ estimates. Its non-GAAP profit of $1.55 per share was 6% above analysts’ consensus estimates.
Via StockStory · February 19, 2026
Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 5.6% in the afternoon session after the company posted strong fourth-quarter 2025 financial results that beat Wall Street's expectations.
Via StockStory · February 18, 2026
Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings per share (EPS) of $1.55, significantly outstripping Wall Street’s consensus estimate of $1.46. Revenue for the quarter reached $783.8 million,
Via MarketMinute · February 18, 2026
What's going on in today's session: S&P500 moverschartmill.com
Via Chartmill · February 18, 2026
Wednesday's session: gap up and gap down stock in the S&P500 indexchartmill.com
Via Chartmill · February 18, 2026
What's going on in today's pre-market session: S&P500 moverschartmill.com
Via Chartmill · February 18, 2026
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 31.2% year on year to $783.8 million. The company expects next quarter’s revenue to be around $716.9 million, close to analysts’ estimates. Its non-GAAP profit of $1.55 per share was 6% above analysts’ consensus estimates.
Via StockStory · February 18, 2026
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what to look for.
Via StockStory · February 16, 2026
Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion.
The best of these businesses balance profitability with reinvestment, setting themselves up for long-term success.
Via StockStory · February 10, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via StockStory · February 8, 2026
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Via StockStory · February 1, 2026
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Via Chartmill · January 23, 2026
Which S&P500 stocks are moving on Friday?chartmill.com
Via Chartmill · January 23, 2026
